TITLE

Roche's Tamiflu Gets First Approval As New Flu Treatment

PUB. DATE
November 1999
SOURCE
Worldwide Biotech;Nov99, Vol. 11 Issue 11, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the approval of Tamiflu, a drug developed by Hoffmann-La Roche Inc. and Gilead Sciences Inc., by the Swiss Regulatory Authority for the treatment of influenza.
ACCESSION #
2435863

 

Related Articles

  • Competition between flu drugs feverishly anticipated. Glaser, Vicki // Nature Biotechnology;Nov99, Vol. 17 Issue 11, p1059 

    Reports on the introduction of two influenza drugs, Relenza developed by London, England-based company Glaxo Wellcome Inc. and Tamiflu developed by Nutley, New Jersy-based company Hoffmann-La Roche Inc. and Foster City, California-based company Gilead Sciences Inc. Function of these drugs;...

  • Stocking your medicine chest for the flu season. George, Connie // New Hampshire Business Review;1/10/2003, Vol. 25 Issue 1, p17A 

    Presents several suggestions for stocking the medicine cabinet in preparation for flu-like syndromes. List of fluid replacement; Availability of over-the-counter medications; Medicines for dealing with a gastrointestinal illness.

  • Flu Fighters. Growney, Kate; Murray, Mary // Harper's Bazaar;Jan2000, Issue 3458, p62 

    Focuses on influenza medications Relenza and Tamiflu.

  • Daily Capsule Bolsters Flu-Fighting Arsenal.  // FDA Consumer;Jan/Feb2000, Vol. 34 Issue 1, p4 

    Details the effectiveness of Tamiflu (oseltamivir phosphate) in shortening the symptoms of influenza. Type of influenza where Tamiflu is recommended; When to start treatment with Tamiflu; Dosage; Result of clinical trials; Side effects.

  • Once Again -- The Flu is Upon Us. Kemper, Carol A. // Infectious Disease Alert;Mar2009, Vol. 28 Issue 6, p35 

    The article discusses research on the influenza virus in the U.S. as of January 31, 2009. It references a report published in the 2009 issue of the periodical "The Medical Letter." The current vaccine may not cover the 60% of circulating influenza A isolates and 70% of circulating influenza B...

  • FUSS OVER THE FLU.  // Weekly Reader News - Senior;12/3/2004, Vol. 83 Issue 12, p7 

    Reports on the shortage of influenza vaccine in the U.S. as of December 2004. Number of doses of the vaccine reported to be stolen from a doctor's office in Colorado; Number of people who die every year in the U.S. because of the virus; Tips to prevent the spread of the influenza virus.

  • One Flu Over. Bauman, Alisa // Runner's World;Dec2000, Vol. 35 Issue 12, p26 

    Presents an advice on the medications that can be taken in treating flu attacks.

  • Decreased antibody response to influenza vaccine among...  // MMWR: Morbidity & Mortality Weekly Report;12/20/1996, Vol. 45 Issue 50, p1100 

    Presents an evaluation of antibody responses to the 1996-97 influenza vaccine among nursing home residents, by the New York State Department of Health. Review of nursing home medical records; Factors influencing the antibody responses of nursing home residents to the vaccine; Information on an...

  • Recent changes in the trends of seasonal influenza outbreaks in the Nagano Prefectural area of Japan: an oseltamivir effect? Kozo Yasui; Yoshiro Amano; Isaki Minami; Shinichi Nakamura; Yohei Akazawa; Noriko Uchida // Journal of Infection & Chemotherapy (Springer Science & Business;Dec2007, Vol. 13 Issue 6, p429 

    Abstract  We carried out a study to assess the pharmacological role of oseltamivir in the regulation of influenza epidemics in Japan, examining data for the years 1998 to 2006 from Nagano Prefecture. Oseltamivir is effective for the treatment of influenza, and its use in Japan has...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics